Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Selenium Sulfide for Refractory Obsessive Compulsive Disorder
IRCT20180212038699N1Phase 3Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in obsessive compulsive disorder (OCD) comparing Selenium sulfide with Placebo (2 arms). Started Jan 2018; status: completed.
02
Drugs
selenium disulfide
03
Conditions
obsessive compulsive disorder (OCD)
Beyond the preview
Go deeper on IRCT20180212038699N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180212038699N1.